LSV Asset Management’s Avanos Medical AVNS Stock Holding History

LSV Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$490K	Sell	19,700 -38,600	-66%	-$904K	﹤0.01%	739
2026 Q1	$817K	Sell	58,300 -16,493	-22%	-$222K	﹤0.01%	654
2025 Q4	$840K	Hold	74,793	–	–	﹤0.01%	649
2025 Q3	$865K	Hold	74,793	–	–	﹤0.01%	649
2025 Q2	$915K	Hold	74,793	–	–	﹤0.01%	616
2025 Q1	$1.07M	Buy	74,793 +31,493	+73%	+$492K	﹤0.01%	616
2024 Q4	$689K	Buy	43,300 +17,600	+68%	+$348K	﹤0.01%	641
2024 Q3	$618K	Buy	25,700 +13,000	+102%	+$297K	﹤0.01%	679
2024 Q2	$253K	Hold	12,700	–	–	﹤0.01%	779
2024 Q1	$253K	Hold	12,700	–	–	﹤0.01%	784
2023 Q4	$285K	Sell	12,700 -23,800	-65%	-$491K	﹤0.01%	786
2023 Q3	$738K	Hold	36,500	–	–	﹤0.01%	708
2023 Q2	$933K	Hold	36,500	–	–	﹤0.01%	700
2023 Q1	$1.09M	Buy	+36,500	New	+$1.06M	﹤0.01%	660
2016 Q3	–	Sell	-19,199	Closed	-$624K	–	1030
2016 Q2	$624K	Buy	19,199 +18,300	+2,036%	+$561K	﹤0.01%	840
2016 Q1	$25K	Hold	899	–	–	﹤0.01%	1014
2015 Q4	$30K	Hold	899	–	–	﹤0.01%	989
2015 Q3	$25K	Hold	899	–	–	﹤0.01%	953
2015 Q2	$36K	Hold	899	–	–	﹤0.01%	932
2015 Q1	$44K	Hold	899	–	–	﹤0.01%	884
2014 Q4	$40K	Buy	+899	New	+$35.3K	﹤0.01%	906

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

LSV Asset Management's AVNS Position: Q2 2026 in Review

LSV Asset Management reduced its Avanos Medical (AVNS) stake by 66% in Q2 2026, selling an estimated $904K and leaving 19,700 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

LSV Asset Management first reported a position in AVNS in Q4 2014 and has held it in 21 quarters since. The position peaked at $1.09M in Q1 2023. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

LSV Asset Management held 19,700 shares of Avanos Medical worth $490K as of Q2 2026.
LSV Asset Management sold 38,600 Avanos Medical shares in Q2 2026, an estimated $904K.
Avanos Medical made up ﹤0.01% of LSV Asset Management's portfolio in Q2 2026, its #739 holding.
LSV Asset Management first reported a position in Avanos Medical in Q4 2014 and has held it in 21 quarters since.
LSV Asset Management's Avanos Medical position peaked at $1.09M in Q1 2023.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.